Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2G0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,215
Award facts
- Contract value 100% obligated
- $15,214.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,214.71 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Dupixent 300 mg/2 ml pens (2 ml quantity). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 13, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic immunosuppressant medication used to treat conditions including atopic dermatitis, asthma, and eosinophilic conditions, making this delivery order part of the agency's broader pharmaceutical procurement for military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen competes on a full and open basis for federal contracts and maintains a critical role in the Defense Logistics Agency's Medical Supply Chain, demonstrating capability to efficiently fulfill essential pharmaceutical needs for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FA2G0?
SPE2DR26FA2G0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FA2G0 worth?
The government has obligated $15,215 on SPE2DR26FA2G0.
Is contract SPE2DR26FA2G0 an order under another contract?
Yes. SPE2DR26FA2G0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2G0 competed?
The extent of competition for SPE2DR26FA2G0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award